Changes of Microbiota in Irritable Bowel Syndrome Patients
NCT01679730 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2015-03-10
Summary
To investigate the changes of gastrointestinal microbiota in irritable bowel syndrome patients by hydrogen breath test and molecular-based analysis of microbiota in gastrointestinal tract
Conditions
- Mucosa Associated Bacteria in Small Intestine
Sponsors & Collaborators
-
Far Eastern Memorial Hospital
lead OTHER
Eligibility
- Min Age
- 20 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-06-30
- Primary Completion
- 2016-04-30
Countries
- Taiwan
Study Locations
More Related Trials
-
Immunological Change and the Single Nucleotide Polymorphism (SNP) in Children With Irritable Bowel Syndrome (IBS)
NCT01131442 ·Status: UNKNOWN
-
Efficacy of Hydrogen Breath Test in the Patients With Irritable Bowel Syndrome
NCT02242175 ·Status: UNKNOWN ·Phase: NA
-
The Effect of Prebiotics on the Microbiome in Irritable Bowel Syndrome Patients: The Diet and Microbiome Study
NCT01829932 ·Status: COMPLETED ·Phase: NA
-
Developing Novel Microbiota-Targeted Therapies for Irritable Bowel Syndrome
NCT02249169 ·Status: COMPLETED
-
Colonoscopic Probiotics Spray in Irritable Bowel Syndrome
NCT05864716 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Pathophysiological Effects of Persistently Colonized Microbiome on Irritable Bowel Syndrome
NCT06013410 ·Status: RECRUITING ·Phase: NA
-
Efficacy of a Probiotic Blend to Reduce Gastrointestinal Symptoms in Patients With Irritable Bowel Syndrome
NCT05819281 ·Status: UNKNOWN ·Phase: PHASE2
-
Neurotrophic Factors, Tight Junction Proteins, and Cytokines in IBS
NCT03675100 ·Status: COMPLETED ·Phase: NA
-
Hydrogen Breath Test an Instrument to Predict Rifaximin-Response in Irritable Bowel Syndrome Predominant Diarrhea
NCT03729271 ·Status: COMPLETED ·Phase: PHASE4
-
Altered Faecal Protease Activity in Irritable Bowel Syndrome Patients in China
NCT01060527 ·Status: UNKNOWN
-
Changes in Microbiota and Metabolomic Profile Between Rifaximin Responders and Non-responders In Diarrhoea-Predominant Irritable Bowel Syndrome
NCT03557788 ·Status: COMPLETED ·Phase: PHASE4
-
Abnormal Expression Proteins, Mitochondrial DNA and miRNA of Irritable Bowel Syndrome
NCT01028898 ·Status: UNKNOWN
-
The Expression of the Ionotropic Glutamate Receptors in Colon of IBS
NCT02512146 ·Status: UNKNOWN
-
Comparison of Microbiota and Quality of Life for a Low FODMAPs and Standard Dietary in Irritable Bowel Syndrome Patients
NCT02902926 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety Evaluation of Fecal Microbiota Transplantation in Irritable Bowel Syndrome
NCT05740319 ·Status: RECRUITING ·Phase: NA
-
A Longitudinal Study to Identify IBS Phenotypes Using Fecal Microbiota and Hydrogen Breath Testing
NCT03219528 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of FODMAPs on Mucosal Inflammation in IBS Patients
NCT03221790 ·Status: UNKNOWN ·Phase: NA
-
A Clinical Study to Determine the Safety and Efficacy of An Oral Probiotic Supplementation in the Management of Irritable Bowel Syndrome With Protein Digestion.
NCT06687720 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Microbiota Profiling in IBS
NCT03720314 ·Status: COMPLETED
-
The Effect of Probiotics on Symptoms and Intestinal Flora in Patients With Irritable Bowel Syndrome
NCT02108119 ·Status: COMPLETED ·Phase: PHASE2
-
Manipulation of Visceral Hypersensitivity With Probiotic Bacteria in Irritable Bowel Syndrome
NCT01139736 ·Status: COMPLETED ·Phase: PHASE4
-
Irritable Bowel Syndrome Survey in Gastroenterological Adult Outpatients in China
NCT02955316 ·Status: COMPLETED
-
A Cross-sectional Study on IBS Subtypes, Chinese Medicine Pattern and Host-gut Microbiota Metabolic Interactions
NCT02822677 ·Status: COMPLETED
-
Efficacy of Rifaximin to Treat Diarrhea-predominant Irritable Bowel Syndrome
NCT02565654 ·Status: UNKNOWN
-
A Multi-center Human Study to Evaluate the Efficacy and Safety of ®GI Flora in Subjects With Irritable Bowel Syndrome
NCT02419027 ·Status: UNKNOWN ·Phase: NA